Key player · Company profile

Gilead Sciences, Inc.

Named as a key player in 66 of our reports, across 33 regions and countries.

Fastest-growing markets they play in

2023–2033 CAGR · estimates

  1. 1Cell Based Immunotherapy (India) 26%
  2. 2HIV Drugs (India) 8.8%

Where they show up

  • Pharmaceuticals66

Geographies

Recent reports naming Gilead Sciences, Inc.

Search all reports for Gilead Sciences, Inc. All companies